https://phrma.org/blogs/rss PhRMA Blog RSS Feed for Sitecore Send Repeatable Campaigns en-us 13772 https://phrma.org/blog/world-sickle-cell-day-recognizing-the-promise-of-gene-therapy Drew Voytal, June 19, 2026 Today is World Sickle Cell Day, an opportunity to recognize the patients, families and communities affected by sickle cell disease — and to underscore the biopharmaceutical industry's ongoing efforts to advancing new treatments for this life-altering condition.  Fri, 19 Jun 2026 04:00:00 GMT 13773 https://phrma.org/blog/mfn-threatens-the-generic-market-patients-depend-on Brianna Allen, June 18, 2026 Policymakers are pitching Most Favored Nation drug pricing as a cost-cutting fix, but in reality, it’s a blunt price control that risks doing the opposite by weakening the low-cost generics market.  Thu, 18 Jun 2026 04:00:00 GMT 13771 https://phrma.org/blog/new-america-cures-ad-highlights-that-u-s-patients-get-new-medicines-first Megan Van Etten, June 15, 2026 “When your child gets sick, time is everything.”   Mon, 15 Jun 2026 13:29:01 GMT 13762 https://phrma.org/blog/nearly-80-researchers-advocate-on-capitol-hill Stephen J. Ubl, June 11, 2026 Yesterday, PhRMA welcomed 76 researchers from 25 member companies to Washington, D.C. for our annual Federal Researcher Fly-in event. The researchers met with over 175 congressional offices to talk about the importance of protecting their ability to innovate. Thu, 11 Jun 2026 04:00:00 GMT 13753 https://phrma.org/blog/private-equity-s-new-play-become-a-nonprofit-to-profit-off-340b Elise Shutzer, June 5, 2026 A private equity-backed hospital chain is transforming into a nonprofit, in an effort to tap into the unchecked profits generated from the 340B hospital markup program. This should raise some serious concerns about the integrity of the 340B program.  Fri, 05 Jun 2026 16:42:12 GMT 13752 https://phrma.org/blog/patients-speak-out-mfn-won-t-address-my-affordability-concerns Matthew Norawong, June 4, 2026 Voters for Cures works to drive patient-centered progress in innovation, affordability and access and pushes for necessary, positive and long-term change to better address the needs of diverse patient communities. As policymakers continue to debate harmful price-setting policies in the form of Most Favored Nation Pricing (MFN), hear what these advocates have to say.  Thu, 04 Jun 2026 18:45:00 GMT 13716 https://phrma.org/blog/intellectual-property-and-hatch-waxman-a-blueprint-for-american-leadership-and-patient-savings David Korn, June 2, 2026 American patients enjoy access to more treatment options than anywhere else in the world. This success is built in large part on two legal foundations: Tue, 02 Jun 2026 04:00:00 GMT 13725 https://phrma.org/blog/mfn-price-controls-threaten-american-jobs-and-the-u-s-economy Matthew Norawong, May 28, 2026 Policymakers are weighing a misguided price-control policy that would put U.S. jobs, manufacturing and economic strength at risk, all while doing little to lower costs for patients. Thu, 28 May 2026 17:14:26 GMT 13724 https://phrma.org/blog/america-s-cancer-research-progress-is-real-and-worth-protecting Drew Voytal, May 28, 2026 National Cancer Research Month is a reminder that smart policies and sustained investment have made America the global leader in cancer research. Maintaining this important leadership is not guaranteed. Thu, 28 May 2026 15:46:07 GMT 13723 https://phrma.org/blog/340b-is-growing-but-it-is-unclear-if-illinois-patients-benefit Will May, May 27, 2026 A program distorted: Congress created the federal 340B program in 1992 to help vulnerable and uninsured patients access medicines. What once served fewer than 100 safety-net hospitals is now the second-largest federal prescription drug program—topping $81 billion and serving as a cash cow for large hospital systems, for-profit pharmacies, pharmacy benefit managers (PBMs) and other middlemen. Wed, 27 May 2026 17:20:04 GMT 13722 https://phrma.org/blog/ahead-of-asco-cancer-innovation-is-promising-but-policy-choices-matter Mike Ybarra, May 26, 2026 I’m looking forward to being back in Chicago for the American Society of Clinical Oncology (ASCO) annual meeting as we stand on the cusp of a new era in cancer care. Between the data presented at the American Association for Cancer Research last month and what we expect to see at ASCO, the next generation of treatments is coming into focus. Tue, 26 May 2026 17:41:26 GMT 13714 https://phrma.org/blog/new-research-reinforces-the-importance-of-hepatitis-b-vaccination-at-birth Carolyn Ha, May 21, 2026 May is Hepatitis Awareness Month, and new research underscores a key point: Giving the hepatitis B vaccine at birth is critical to preventing serious, often lifelong disease. Thu, 21 May 2026 17:30:10 GMT 13711 https://phrma.org/blog/state-price-setting-boards-create-more-questions-than-answers Reid Porter, May 20, 2026 The big picture: States are rolling out complex drug price-setting efforts—but there is no evidence yet that patients are or will save money at the pharmacy counter. Wed, 20 May 2026 04:00:00 GMT 13710 https://phrma.org/blog/fox-business-spotlights-hospitals-abuse-of-the-340b-program Chanse Jones, May 15, 2026 New Fox Business reporting is putting a national spotlight on growing concerns around the 340B program, including questions about transparency, accountability and whether patients are truly benefiting from the discounts. Fri, 15 May 2026 16:45:29 GMT